Biohaven Ltd.
BHVN
$8.19
-$0.18-2.15%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -26.31% | 3.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -37.58% | -19.99% | |||
| Operating Income | 37.58% | 19.99% | |||
| Income Before Tax | 16.17% | 12.46% | |||
| Income Tax Expenses | 58.82% | -15.33% | |||
| Earnings from Continuing Operations | 16.08% | 12.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.08% | 12.47% | |||
| EBIT | 37.58% | 19.99% | |||
| EBITDA | 37.96% | 20.73% | |||
| EPS Basic | 26.11% | 15.31% | |||
| Normalized Basic EPS | 44.67% | 15.42% | |||
| EPS Diluted | 26.11% | 15.31% | |||
| Normalized Diluted EPS | 44.67% | 15.42% | |||
| Average Basic Shares Outstanding | 13.58% | 3.36% | |||
| Average Diluted Shares Outstanding | 13.58% | 3.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||